Stock in Tylenol’s parent company rallies after Trump’s unproven claims

0 StatusTip
Tylenol's parent company, Kenvue, saw its stock price rebound in premarket trading on Tuesday after U.S. President Donald Trump made unfounded claims about the drug.

from : World https://ift.tt/LYpRCFt
via

Post a Comment

0 Comments
* Please Don't Spam Here. All the Comments are Reviewed by Admin.

About Us

Galaxy Template is Designed Theme for Giving Enhanced look Various Features are available Which is designed in User friendly to handle by Piki Developers. Simple and elegant themes for making it more comfortable